Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients

Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients

OBJECTIVE: To determine whether recombinant factor VIIa (rFVIIa) is associated with increased survival and/or thromboembolic complications. INTRODUCTION: Uncontrollable hemorrhage is the main cause of early mortality in trauma. rFVIIa has been suggested for the management of refractory hemorrhage. H...

Full description

Bibliographic Details
Main Authors: Bartolomeu Nascimento, Yulia Lin, Jeannie Callum, Marciano Reis, Ruxandra Pinto, Sandro Rizoli
Format: Article
Language:English
Published: Elsevier España 2011-01-01
Series:Clinics
Subjects:
Coagulopathy
Bleeding
Thromboembolic events
Hemorrhagic shock
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000100018

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000100018

Similar Items